Cefcapene Pivoxil Hydrochloride Monohydrate is the active pharmaceutical ingredient (API) for a third-generation oral cephalosporin antibiotic prodrug. It is used in the manufacture of medications effective against a broad spectrum of gram-positive and gram-negative bacteria, treating respiratory tract infections (e.g., bronchitis, pneumonia), skin and soft tissue infections, urinary tract infections, and otitis media. The compound inhibits bacterial cell wall synthesis, leading to bacterial cell death. This high-purity reagent (≥98.0% HPLC) is ideal for pharmaceutical research, development, and production.